已入深夜,您辛苦了!由于当前在线用户较少,发布求助请尽量完整地填写文献信息,科研通机器人24小时在线,伴您度过漫漫科研夜!祝你早点完成任务,早点休息,好梦!

A Double-Blind Placebo-Controlled Trial of Lamotrigine as an Antidepressant Augmentation Agent in Treatment-Refractory Unipolar Depression

拉莫三嗪 安慰剂 帕罗西汀 评定量表 抗抑郁药 萧条(经济学) 心理学 随机对照试验 内科学 临床试验 精神科 重性抑郁障碍 医学 焦虑 癫痫 病理 经济 宏观经济学 认知 替代医学 发展心理学
作者
James G. Barbee,Thomas R. Thompson,Nowal J. Jamhour,Jonathan W. Stewart,Erich J. Conrad,Frederick W. Reimherr,Paul M. Thompson,Richard C. Shelton
出处
期刊:The Journal of Clinical Psychiatry [Physicians Postgraduate Press, Inc.]
卷期号:72 (10): 1405-1412 被引量:75
标识
DOI:10.4088/jcp.09m05355gre
摘要

Article AbstractBackground: Previous reports have suggested that lamotrigine is effective as an antidepressant augmentation agent in patients with treatment-resistant unipolar depression. This study is the largest double-blind placebo-controlled study conducted to date of lamotrigine in this role. Method: In this multicenter trial, conducted at 19 sites, patients aged 18-65 years with a DSM-IV/ICD-10 diagnosis of unipolar, nonpsychotic major depressive disorder (confirmed by the Mini-International Neuropsychiatric Interview) who had failed at least 1 adequate trial of an antidepressant (N = 183) were first treated for 8 weeks with open-label paroxetine or paroxetine controlled-release in dosages up to 50 mg/d or 62.5 mg/d, respectively. Individuals with a 17-item Hamilton Depression Rating Scale (HDRS-17) score ≥ 15 (n = 96) were then randomized on a double-blind basis to receive either placebo or lamotrigine in dosages titrated upward to a maximum of 400 mg/d for 10 weeks. Sixty-five patients completed the study. The primary outcome measure was the Montgomery-Asberg Depression Rating Scale (MADRS), and the main secondary outcome measures were the HDRS-17 and Clinical Global Impressions-Severity of Illness (CGI-S) and Clinical Global Impressions-Improvement (CGI-I) ratings. Data were collected from 2003 to 2006. Results: Results of the primary efficacy analysis of the randomized patients using the MADRS, HDRS-17, CGI-S, and CGI-I did not demonstrate a statistically significant difference between lamotrigine and placebo groups, although some secondary analyses were suggestive of efficacy, particularly in those patients who completed the study (completer analysis) and in more severely ill patients (HDRS-17 ≥ 25). Conclusions: This add-on study of patients with treatment-resistant depression failed to detect a statistically significant difference between lamotrigine and placebo given for 10 weeks. However, post hoc analyses suggest that future studies of lamotrigine's efficacy might focus on specific subgroups with depression. Trial Registration: clinicaltrials.gov Identifier: NCT00901407J Clin PsychiatrySubmitted: May 8, 2009; accepted April 6, 2010. Online ahead of print: February 22, 2011 (doi:10.4088/JCP.09m05355gre). Corresponding author: James G. Barbee, MD, 3439 Magazine Street, New Orleans, LA 70115 (jgbmd@att.net).
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
1秒前
Wenjian7761完成签到,获得积分10
1秒前
慕青的应助被楠楠采纳,获得10
3秒前
421完成签到,获得积分10
4秒前
4秒前
Akim的应助被赵涵采纳,获得10
6秒前
7秒前
朱雀发布了新的文献求助10
9秒前
10秒前
zyb完成签到 ,获得积分10
12秒前
小兵完成签到,获得积分10
13秒前
万能图书馆的应助被灵巧乐儿采纳,获得10
13秒前
楠楠发布了新的文献求助10
14秒前
17秒前
wwwjy完成签到 ,获得积分10
18秒前
无语的汉堡完成签到 ,获得积分10
20秒前
20秒前
曹琳完成签到,获得积分10
23秒前
徐zhipei完成签到 ,获得积分10
24秒前
灵巧乐儿发布了新的文献求助10
25秒前
原神大王发布了新的文献求助10
28秒前
28秒前
HONG完成签到 ,获得积分10
29秒前
31秒前
33秒前
33秒前
wwwwwww关注了科研通微信公众号
34秒前
灵巧乐儿完成签到,获得积分10
35秒前
37秒前
zzz完成签到,获得积分10
38秒前
直率的惜寒完成签到,获得积分10
39秒前
39秒前
kiko发布了新的文献求助30
41秒前
故意的棒棒糖完成签到 ,获得积分10
42秒前
44秒前
小新完成签到 ,获得积分10
44秒前
宋忠赫完成签到,获得积分10
44秒前
46秒前
小阿然完成签到 ,获得积分10
46秒前
YOSH发布了新的文献求助10
47秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
拉伸高分子熔体中缠结行为的模拟和小角中子散射研究 2000
Sex, Aging, and Death in a Medieval Medical Compendium: Trinity College Cambridge MS R.14.52, Its Texts, Language, and Scribe 500
高分子基功能界面水蒸发材料与应用研究 500
外场增强的水汽发电研究 500
基于结构调控的功能化水诱导发电材料与器件研究 500
基于界面调控的高效湿气发电材料与器件研究 500
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 计算机科学 工程类 有机化学 化学工程 生物化学 物理 复合材料 内科学 催化作用 光电子学 人工智能 细胞生物学 无机化学 物理化学 数学
热门帖子
关注 科研通微信公众号,转发送积分 8189808
求助须知:如何正确求助?哪些是违规求助? 9576985
关于积分的说明 21850907
捐赠科研通 7787770
什么是DOI,文献DOI怎么找? 3435793
关于科研通互助平台的介绍 2559825
邀请新用户注册赠送积分活动 2482680